메뉴 건너뛰기




Volumn 59, Issue 1, 2013, Pages 69-87

Management of non-alcoholic fatty liver disease

Author keywords

Bariatric surgery; Diet; Exercise; Metformin; Non alcoholic fatty liver disease

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; BIGUANIDE DERIVATIVE; CARBOHYDRATE; EXENDIN 4; FAT; GLITAZONE DERIVATIVE; INSULIN SENSITIZING AGENT; LIRAGLUTIDE; LOSARTAN; METFORMIN; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SIMVASTATIN; TELMISARTAN; URSODEOXYCHOLIC ACID;

EID: 84876545973     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (10)

References (122)
  • 1
    • 0033038672 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
    • DOI 10.1016/S0016-5085(99)70506-8
    • Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic Fatty Liver Disease: A Spectrum of Clinical and Pathological Severity. Gastroenterology 1999;116:1413-9. (Pubitemid 29258890)
    • (1999) Gastroenterology , vol.116 , Issue.6 , pp. 1413-1419
    • Matteoni, C.A.1    Younossi, Z.M.2    Gramlich, T.3    Boparai, N.4    Yao, C.L.5    McCullough, A.J.6
  • 2
    • 84861591910 scopus 로고    scopus 로고
    • The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
    • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-609.
    • (2012) Gastroenterology , vol.142 , pp. 1592-1609
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3    Diehl, A.M.4    Brunt, E.M.5    Cusi, K.6
  • 3
    • 0031947715 scopus 로고    scopus 로고
    • Steatohepatitis: A tale of two "Hits"?
    • Day CP, James OF. Steatohepatitis: a tale of two "Hits"? Gastroenterology 1998;114:842-5.
    • (1998) Gastroenterology , vol.114 , pp. 842-845
    • Day, C.P.1    James, O.F.2
  • 4
    • 77149177995 scopus 로고    scopus 로고
    • Implications of diet on nonalcoholic fatty liver disease
    • Sullivan S. Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol 2010;26:160-4.
    • (2010) Curr Opin Gastroenterol , vol.26 , pp. 160-164
    • Sullivan, S.1
  • 5
    • 72449161164 scopus 로고    scopus 로고
    • Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults
    • Silver Spring
    • Shah K, Stufflebam A, Hilton TN, Sinacore DR, Klein S, Villareal DT. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring) 2009;17:2162-8.
    • (2009) Obesity , vol.17 , pp. 2162-2168
    • Shah, K.1    Stufflebam, A.2    Hilton, T.N.3    Sinacore, D.R.4    Klein, S.5    Villareal, D.T.6
  • 9
    • 84857668720 scopus 로고    scopus 로고
    • The role of diet and nutrient composition in nonalcoholic fatty liver disease
    • McCarthy EM, Rinella ME. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J Acad Nutr Diet 2012;112:401-9.
    • (2012) J Acad Nutr Diet , vol.112 , pp. 401-409
    • McCarthy, E.M.1    Rinella, M.E.2
  • 10
    • 79955457155 scopus 로고    scopus 로고
    • Short-term weight loss and hepatic triglyceride reduction: Evidence of a metabolic advantage with dietary carbohydrate restriction
    • Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 2011;93:1048-52.
    • (2011) Am J Clin Nutr , vol.93 , pp. 1048-1052
    • Browning, J.D.1    Baker, J.A.2    Rogers, T.3    Davis, J.4    Satapati, S.5    Burgess, S.C.6
  • 11
    • 66849124938 scopus 로고    scopus 로고
    • Fructose Overconsumption Causes Dyslipidemia and Ectopic Lipid Deposition in Healthy Subjects with and without a Family History of Type 2 Diabetes
    • Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C et al. Fructose Overconsumption Causes Dyslipidemia and Ectopic Lipid Deposition in Healthy Subjects with and without a Family History of Type 2 Diabetes. Am J Clin Nutr 2009;89:1760-5.
    • (2009) Am J Clin Nutr , vol.89 , pp. 1760-1765
    • Le, K.A.1    Ith, M.2    Kreis, R.3    Faeh, D.4    Bortolotti, M.5    Tran, C.6
  • 12
    • 70350570495 scopus 로고    scopus 로고
    • Diabetes of the Liver: The Link between Nonalcoholic Fatty Liver Disease and HFCS-55
    • Silver Spring
    • Collison KS, Saleh SM, Bakheet RH, Al-Rabiah RK, Inglis AL, Makhoul NJ et al. Diabetes of the Liver: The Link between Nonalcoholic Fatty Liver Disease and HFCS-55. Obesity (Silver Spring) 2009;17:2003-13.
    • (2009) Obesity , vol.17 , pp. 2003-2013
    • Collison, K.S.1    Saleh, S.M.2    Bakheet, R.H.3    Al-Rabiah, R.K.4    Inglis, A.L.5    Makhoul, N.J.6
  • 13
    • 70349661988 scopus 로고    scopus 로고
    • Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: Systematic review and meta-analysis of experimental trials in humans
    • Sievenpiper JL, Carleton AJ, Chatha S, Jiang HY, de Souza RJ, Beyene J et al. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care 2009;32:1930-7.
    • (2009) Diabetes Care , vol.32 , pp. 1930-1937
    • Sievenpiper, J.L.1    Carleton, A.J.2    Chatha, S.3    Jiang, H.Y.4    De Souza, R.J.5    Beyene, J.6
  • 14
    • 78651331337 scopus 로고    scopus 로고
    • A low-glycemic index diet combined with exercise reduces insulin resistance, post-prandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans
    • Solomon TP, Haus JM, Kelly KR, Cook MD, Filion J, Rocco M et al. A low-glycemic index diet combined with exercise reduces insulin resistance, post-prandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr 2010;92:1359-68.
    • (2010) Am J Clin Nutr , vol.92 , pp. 1359-1368
    • Solomon, T.P.1    Haus, J.M.2    Kelly, K.R.3    Cook, M.D.4    Filion, J.5    Rocco, M.6
  • 16
    • 34547882082 scopus 로고    scopus 로고
    • Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease
    • Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007;86:285-300. (Pubitemid 47256910)
    • (2007) American Journal of Clinical Nutrition , vol.86 , Issue.2 , pp. 285-300
    • Zivkovic, A.M.1    German, J.B.2    Sanyal, A.J.3
  • 17
    • 84862517200 scopus 로고    scopus 로고
    • Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials
    • Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012;55:885-904.
    • (2012) Diabetologia , vol.55 , pp. 885-904
    • Musso, G.1    Cassader, M.2    Rosina, F.3    Gambino, R.4
  • 18
    • 84856957313 scopus 로고    scopus 로고
    • Pathophysiology guided treatment of nonalcoholic steatohepatitis
    • Nguyen TA, Sanyal AJ. Pathophysiology guided treatment of nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2012;27(Suppl 2):58-64.
    • (2012) J Gastroenterol Hepatol , vol.27 , Issue.SUPPL. 2 , pp. 58-64
    • Nguyen, T.A.1    Sanyal, A.J.2
  • 19
    • 77954235797 scopus 로고    scopus 로고
    • Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease
    • Johnson NA, George J. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 2010;52:370-81.
    • (2010) Hepatology , vol.52 , pp. 370-381
    • Johnson, N.A.1    George, J.2
  • 20
    • 75149132023 scopus 로고    scopus 로고
    • Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance
    • Haus JM, Solomon TP, Marchetti CM, Edmison JM, Gonzalez F, Kirwan JP. Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance. J Clin Endocrinol Metab 2010;95:323-7.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 323-327
    • Haus, J.M.1    Solomon, T.P.2    Marchetti, C.M.3    Edmison, J.M.4    Gonzalez, F.5    Kirwan, J.P.6
  • 23
    • 70350072281 scopus 로고    scopus 로고
    • Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss
    • Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009;50:1105-12.
    • (2009) Hepatology , vol.50 , pp. 1105-1112
    • Johnson, N.A.1    Sachinwalla, T.2    Walton, D.W.3    Smith, K.4    Armstrong, A.5    Thompson, M.W.6
  • 24
    • 33645225309 scopus 로고    scopus 로고
    • Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis
    • Sreenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2006;21:191-8.
    • (2006) J Gastroenterol Hepatol , vol.21 , pp. 191-198
    • Sreenivasa Baba, C.1    Alexander, G.2    Kalyani, B.3    Pandey, R.4    Rastogi, S.5    Pandey, A.6
  • 25
    • 27744490794 scopus 로고    scopus 로고
    • Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
    • DOI 10.1016/j.jhep.2005.06.008, PII S0168827805004356
    • Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43:1060-6. (Pubitemid 41627993)
    • (2005) Journal of Hepatology , vol.43 , Issue.6 , pp. 1060-1066
    • Suzuki, A.1    Lindor, K.2    Saver, J.S.3    Lymp, J.4    Mendes, F.5    Muto, A.6    Okada, T.7    Angulo, P.8
  • 26
    • 79957917060 scopus 로고    scopus 로고
    • The role of lifestyle changes in the management of chronic liver disease
    • Nobili V, Carter-Kent C, Feldstein AE. The role of lifestyle changes in the management of chronic liver disease. BMC Med 2011;9:70-7015-9-70.
    • (2011) BMC Med , vol.9
    • Nobili, V.1    Carter-Kent, C.2    Feldstein, A.E.3
  • 28
    • 73449116035 scopus 로고    scopus 로고
    • Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
    • Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-9.
    • (2010) Hepatology , vol.51 , pp. 121-129
    • Promrat, K.1    Kleiner, D.E.2    Niemeier, H.M.3    Jackvony, E.4    Kearns, M.5    Wands, J.R.6
  • 29
    • 58949102847 scopus 로고    scopus 로고
    • Orlistat for Overweight Subjects With Nonalcoholic Steatohepatitis: A Randomized, Prospective Trial
    • Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for Overweight Subjects With Nonalcoholic Steatohepatitis: A Randomized, Prospective Trial. Hepatology 2009;49:80-6.
    • (2009) Hepatology , vol.49 , pp. 80-86
    • Harrison, S.A.1    Fecht, W.2    Brunt, E.M.3    Neuschwander-Tetri, B.A.4
  • 30
    • 63049120544 scopus 로고    scopus 로고
    • Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors
    • St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J Gastroenterol Hepatol 2009;24:399-407.
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 399-407
    • St George, A.1    Bauman, A.2    Johnston, A.3    Farrell, G.4    Chey, T.5    George, J.6
  • 31
    • 79952361224 scopus 로고    scopus 로고
    • Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease
    • quiz 469
    • Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB et al. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011;106:460-8; quiz 469.
    • (2011) Am J Gastroenterol , vol.106 , pp. 460-468
    • Kistler, K.D.1    Brunt, E.M.2    Clark, J.M.3    Diehl, A.M.4    Sallis, J.F.5    Schwimmer, J.B.6
  • 32
    • 84862700268 scopus 로고    scopus 로고
    • Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
    • Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012;57:157-66.
    • (2012) J Hepatol , vol.57 , pp. 157-166
    • Keating, S.E.1    Hackett, D.A.2    George, J.3    Johnson, N.A.4
  • 33
    • 56649094325 scopus 로고    scopus 로고
    • Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
    • Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:360-9.
    • (2008) Semin Liver Dis , vol.28 , pp. 360-369
    • Malhi, H.1    Gores, G.J.2
  • 34
    • 33748150370 scopus 로고    scopus 로고
    • Pathophysiology of nonalcoholic steatohepatitis
    • DOI 10.1097/01.mcg.0000168645.86658.22, PII 0000483620060300100005
    • McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006;40(Suppl 1):S17-29. (Pubitemid 44309539)
    • (2006) Journal of Clinical Gastroenterology , vol.40 , Issue.SUPPL. 1
    • McCullough, A.J.1
  • 35
    • 79959554252 scopus 로고    scopus 로고
    • The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis
    • Van Wagner LB, Rinella ME. The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. Therap Adv Gastroenterol 2011;4:249-63.
    • (2011) Therap Adv Gastroenterol , vol.4 , pp. 249-263
    • Van Wagner, L.B.1    Rinella, M.E.2
  • 42
    • 38049131878 scopus 로고    scopus 로고
    • Combination of n-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
    • de Oliveira CP, Stefano JT, de Siqueira ER, Silva LS, de Campos Mazo DF, Lima VM et al. Combination of n-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol Res 2008;38:159-65.
    • (2008) Hepatol Res , vol.38 , pp. 159-165
    • De Oliveira, C.P.1    Stefano, J.T.2    De Siqueira, E.R.3    Silva, L.S.4    De Campos Mazo, D.F.5    Lima, V.M.6
  • 45
    • 79955446251 scopus 로고    scopus 로고
    • Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial
    • Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011;305:1659-68.
    • (2011) JAMA , vol.305 , pp. 1659-1668
    • Lavine, J.E.1    Schwimmer, J.B.2    Van Natta, M.L.3    Molleston, J.P.4    Murray, K.F.5    Rosenthal, P.6
  • 46
    • 0141532275 scopus 로고    scopus 로고
    • Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
    • DOI 10.1053/jhep.2003.50420
    • Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment with the PPAR-Gamma Ligand Rosiglitazone. Hepatology 2003;38:1008-17. (Pubitemid 37221684)
    • (2003) Hepatology , vol.38 , Issue.4 , pp. 1008-1017
    • Neuschwander-Tetri, B.A.1    Brunt, E.M.2    Wehmeier, K.R.3    Oliver, D.4    Bacon, B.R.5
  • 49
    • 75449116707 scopus 로고    scopus 로고
    • Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
    • Ratziu V, Charlotte F, Bernhardt C, Giral P, Halbron M, Lenaour G et al. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial. Hepatology 2010;51:445-53.
    • (2010) Hepatology , vol.51 , pp. 445-453
    • Ratziu, V.1    Charlotte, F.2    Bernhardt, C.3    Giral, P.4    Halbron, M.5    Lenaour, G.6
  • 51
    • 79960029926 scopus 로고    scopus 로고
    • Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
    • Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-85.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 274-285
    • Vernon, G.1    Baranova, A.2    Younossi, Z.M.3
  • 52
    • 34548590934 scopus 로고    scopus 로고
    • Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials
    • DOI 10.1001/jama.298.10.1180
    • Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007;298:1180-8. (Pubitemid 47403104)
    • (2007) Journal of the American Medical Association , vol.298 , Issue.10 , pp. 1180-1188
    • Lincoff, A.M.1    Wolski, K.2    Nicholls, S.J.3    Nissen, S.E.4
  • 53
    • 0033653005 scopus 로고    scopus 로고
    • The location and function of vitamin E in membranes (Review)
    • Wang X, Quinn PJ. The location and function of vitamin E in membranes (Review). Mol Membr Biol 2000;17:143-56.
    • (2000) Mol Membr Biol , vol.17 , pp. 143-156
    • Wang, X.1    Quinn, P.J.2
  • 54
    • 34548316132 scopus 로고    scopus 로고
    • Is vitamin E beneficial in chronic liver disease?
    • DOI 10.1002/hep.21834
    • Hickman I, Macdonald G. Is vitamin E beneficial in chronic liver disease? Hepatology 2007;46:288-90. (Pubitemid 47344760)
    • (2007) Hepatology , vol.46 , Issue.2 , pp. 288-290
    • Hickman, I.1    Macdonald, G.2
  • 56
    • 0032426787 scopus 로고    scopus 로고
    • Vitamin E as a universal antioxidant and stabilizer of biological membranes
    • Evstigneeva RP, Volkov IM, Chudinova W. Vitamin E as a universal antioxidant and stabilizer of biological membranes. Membr Cell Biol 1998;12:151-72. (Pubitemid 29015682)
    • (1998) Membrane and Cell Biology , vol.12 , Issue.2 , pp. 151-172
    • Evstigneeva, R.P.1    Volkov, I.M.2    Chudinova, V.V.3
  • 57
    • 77953199489 scopus 로고    scopus 로고
    • The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis
    • Zamin Jr I, Mattos AA, Mattos AZ, Coral G, Santos D, Rhoden C. The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis. Arq Gastroenterol 2010;47:86-92.
    • (2010) Arq Gastroenterol , vol.47 , pp. 86-92
    • Zamin Jr., I.1    Mattos, A.A.2    Mattos, A.Z.3    Coral, G.4    Santos, D.5    Rhoden, C.6
  • 58
    • 0036180036 scopus 로고    scopus 로고
    • Influence of vitamin E on the levels of fatty acids and MDA in some tissues of diabetic rats
    • DOI 10.1002/cbf.936
    • Celik S, Baydas G, Yilmaz O. Influence of vitamin E on the levels of fatty acids and MDA in some tissues of diabetic rats. Cell Biochem Funct 2002;20:67-71. (Pubitemid 34178184)
    • (2002) Cell Biochemistry and Function , vol.20 , Issue.1 , pp. 67-71
    • Celik, S.1    Bayda, G.2    Ylmaz, O.3
  • 59
    • 0344742265 scopus 로고    scopus 로고
    • Vitamin E and Vitamin C Treatment Improves Fibrosis in Patients with Nonalcoholic Steatohepatitis
    • DOI 10.1111/j.1572-0241.2003.08699.x
    • Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98:2485-90. (Pubitemid 37448761)
    • (2003) American Journal of Gastroenterology , vol.98 , Issue.11 , pp. 2485-2490
    • Harrison, S.A.1    Torgerson, S.2    Hayashi, P.3    Ward, J.4    Schenker, S.5
  • 60
    • 78650971903 scopus 로고    scopus 로고
    • Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: The St Francis Heart Study Randomized Clinical Trial
    • Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study Randomized Clinical Trial. Am J Gastroenterol 2011;106:71-7.
    • (2011) Am J Gastroenterol , vol.106 , pp. 71-77
    • Foster, T.1    Budoff, M.J.2    Saab, S.3    Ahmadi, N.4    Gordon, C.5    Guerci, A.D.6
  • 64
    • 80053954605 scopus 로고    scopus 로고
    • Vitamin E and the risk of prostate cancer: The selenium and vitamin E cancer prevention Trial (SELECT)
    • Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ et al. Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention Trial (SELECT). JAMA 2011;306:1549-56.
    • (2011) JAMA , vol.306 , pp. 1549-1556
    • Klein, E.A.1    Thompson Jr., I.M.2    Tangen, C.M.3    Crowley, J.J.4    Lucia, M.S.5    Goodman, P.J.6
  • 65
    • 79451476075 scopus 로고    scopus 로고
    • The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease
    • Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr 2011;30:6-19.
    • (2011) Clin Nutr , vol.30 , pp. 6-19
    • Shapiro, H.1    Tehilla, M.2    Attal-Singer, J.3    Bruck, R.4    Luzzatti, R.5    Singer, P.6
  • 66
    • 79955592316 scopus 로고    scopus 로고
    • Nutrient intake in Italian obese patients: Relationships with insulin resistance and markers of non-alcoholic fatty liver disease
    • Ricci G, Canducci E, Pasini V, Rossi A, Bersani G, Ricci E et al. Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease. Nutrition 2011;27:672-6.
    • (2011) Nutrition , vol.27 , pp. 672-676
    • Ricci, G.1    Canducci, E.2    Pasini, V.3    Rossi, A.4    Bersani, G.5    Ricci, E.6
  • 67
    • 77957854056 scopus 로고    scopus 로고
    • Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: A cross-sectional study in Japanese men and women
    • Oya J, Nakagami T, Sasaki S, Jimba S, Murakami K, Kasahara T et al. Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. Eur J Clin Nutr 2010;64:1179-85.
    • (2010) Eur J Clin Nutr , vol.64 , pp. 1179-1185
    • Oya, J.1    Nakagami, T.2    Sasaki, S.3    Jimba, S.4    Murakami, K.5    Kasahara, T.6
  • 68
    • 63449137594 scopus 로고    scopus 로고
    • Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
    • Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 2008;14:6395-400.
    • (2008) World J Gastroenterol , vol.14 , pp. 6395-6400
    • Zhu, F.S.1    Liu, S.2    Chen, X.M.3    Huang, Z.G.4    Zhang, D.W.5
  • 70
    • 84867165316 scopus 로고    scopus 로고
    • Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
    • Zein CO, Lopez R, Fu X, Kirwan JP, Yerian LM, McCullough AJ et al. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. Hepatology 2012;56:1291-9.
    • (2012) Hepatology , vol.56 , pp. 1291-1299
    • Zein, C.O.1    Lopez, R.2    Fu, X.3    Kirwan, J.P.4    Yerian, L.M.5    McCullough, A.J.6
  • 71
    • 80055028155 scopus 로고    scopus 로고
    • Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
    • Zein CO, Yerian LM, Gogate P, Lopez R, Kirwan JP, Feldstein AE et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology 2011;54:1610-9.
    • (2011) Hepatology , vol.54 , pp. 1610-1619
    • Zein, C.O.1    Yerian, L.M.2    Gogate, P.3    Lopez, R.4    Kirwan, J.P.5    Feldstein, A.E.6
  • 72
    • 81855197088 scopus 로고    scopus 로고
    • 3-Hydroxyl-3-methylglutaryl co-enzyme a reductase inhibitor use in chronic liver disease: A therapeutic controversy
    • Tzefos M, Olin JL. 3-Hydroxyl-3-methylglutaryl co-enzyme a reductase inhibitor use in chronic liver disease: a therapeutic controversy. J Clin Lipidol 2011;5:450-9.
    • (2011) J Clin Lipidol , vol.5 , pp. 450-459
    • Tzefos, M.1    Olin, J.L.2
  • 74
    • 84864110034 scopus 로고    scopus 로고
    • Management of nonalcoholic steatohepatitis: An evidence-based approach
    • Mahady SE, George J. Management of nonalcoholic steatohepatitis: an evidence-based approach. Clin Liver Dis 2012;16:631-45.
    • (2012) Clin Liver Dis , vol.16 , pp. 631-645
    • Mahady, S.E.1    George, J.2
  • 75
    • 2542546652 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
    • DOI 10.1002/hep.20251
    • Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Non-alcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004;39:1647-54. (Pubitemid 38702666)
    • (2004) Hepatology , vol.39 , Issue.6 , pp. 1647-1654
    • Dixon, J.B.1    Bhathal, P.S.2    Hughes, N.R.3    O'Brien, P.E.4
  • 76
    • 67650951419 scopus 로고    scopus 로고
    • Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease
    • Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009;137:532-40.
    • (2009) Gastroenterology , vol.137 , pp. 532-540
    • Mathurin, P.1    Hollebecque, A.2    Arnalsteen, L.3    Buob, D.4    Leteurtre, E.5    Caiazzo, R.6
  • 79
    • 73449118215 scopus 로고    scopus 로고
    • A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff
    • Oza N, Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Horie H et al. A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol 2009;44:1203-8.
    • (2009) J Gastroenterol , vol.44 , pp. 1203-1208
    • Oza, N.1    Eguchi, Y.2    Mizuta, T.3    Ishibashi, E.4    Kitajima, Y.5    Horie, H.6
  • 80
    • 34447119267 scopus 로고    scopus 로고
    • Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism
    • Shojaee-Moradie F, Baynes KC, Pentecost C, Bell JD, Thomas EL, Jackson NC et al. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 2007;50:404-13.
    • (2007) Diabetologia , vol.50 , pp. 404-413
    • Shojaee-Moradie, F.1    Baynes, K.C.2    Pentecost, C.3    Bell, J.D.4    Thomas, E.L.5    Jackson, N.C.6
  • 82
    • 0025186310 scopus 로고
    • Effect of weight reduction on hepatic abnormalities in overweight patients
    • Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990;99:1408-13. (Pubitemid 20381878)
    • (1990) Gastroenterology , vol.99 , Issue.5 , pp. 1408-1413
    • Palmer, M.1    Schaffner, F.2
  • 83
    • 47149086771 scopus 로고    scopus 로고
    • Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
    • DOI 10.1002/hep.22336
    • Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48:119-28. (Pubitemid 351975537)
    • (2008) Hepatology , vol.48 , Issue.1 , pp. 119-128
    • Nobili, V.1    Manco, M.2    Devito, R.3    Di, C.V.4    Comparcola, D.5    Sartorelli, M.R.6    Piemonte, F.7    Marcellini, M.8    Angulo, P.9
  • 84
    • 47149111845 scopus 로고    scopus 로고
    • Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study
    • DOI 10.1016/j.clinthera.2008.06.012, PII S0149291808002130
    • Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E et al. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther 2008;30:1168-76. (Pubitemid 351978124)
    • (2008) Clinical Therapeutics , vol.30 , Issue.6 , pp. 1168-1176
    • Nobili, V.1    Manco, M.2    Ciampalini, P.3    Alisi, A.4    Devito, R.5    Bugianesi, E.6    Marcellini, M.7    Marchesini, G.8
  • 86
    • 57149123017 scopus 로고    scopus 로고
    • Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease
    • Chen SM, Liu CY, Li SR, Huang HT, Tsai CY, Jou HJ. Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease. J Chin Med Assoc 2008;71:551-8.
    • (2008) J Chin Med Assoc , vol.71 , pp. 551-558
    • Chen, S.M.1    Liu, C.Y.2    Li, S.R.3    Huang, H.T.4    Tsai, C.Y.5    Jou, H.J.6
  • 87
    • 77949266534 scopus 로고    scopus 로고
    • The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the hertfordshire cohort study: A randomised controlled trial
    • Finucane FM, Sharp SJ, Purslow LR, Horton K, Horton J, Savage DB et al. The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the hertfordshire cohort study: a randomised controlled trial. Diabetologia 2010;53:624-31.
    • (2010) Diabetologia , vol.53 , pp. 624-631
    • Finucane, F.M.1    Sharp, S.J.2    Purslow, L.R.3    Horton, K.4    Horton, J.5    Savage, D.B.6
  • 88
    • 78049337151 scopus 로고    scopus 로고
    • Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: A randomized trial
    • Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 2010;304:1795-802.
    • (2010) JAMA , vol.304 , pp. 1795-1802
    • Goodpaster, B.H.1    Delany, J.P.2    Otto, A.D.3    Kuller, L.4    Vockley, J.5    South-Paul, J.E.6
  • 89
    • 80051545931 scopus 로고    scopus 로고
    • Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
    • Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011;60:1278-83.
    • (2011) Gut , vol.60 , pp. 1278-1283
    • Hallsworth, K.1    Fattakhova, G.2    Hollingsworth, K.G.3    Thoma, C.4    Moore, S.5    Taylor, R.6
  • 90
    • 62449157280 scopus 로고    scopus 로고
    • Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors
    • Levinger I, Goodman C, Peake J, Garnham A, Hare DL, Jerums G et al. Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors. Diabet Med 2009;26:220-7.
    • (2009) Diabet Med , vol.26 , pp. 220-227
    • Levinger, I.1    Goodman, C.2    Peake, J.3    Garnham, A.4    Hare, D.L.5    Jerums, G.6
  • 92
    • 77950575040 scopus 로고    scopus 로고
    • Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: A randomized-controlled trial
    • Thompson D, Markovitch D, Betts JA, Mazzatti D, Turner J, Tyrrell RM. Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial. J Appl Physiol 2010;108:769-79.
    • (2010) J Appl Physiol , vol.108 , pp. 769-779
    • Thompson, D.1    Markovitch, D.2    Betts, J.A.3    Mazzatti, D.4    Turner, J.5    Tyrrell, R.M.6
  • 93
    • 42249114813 scopus 로고    scopus 로고
    • Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease
    • Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008;47:1158-66.
    • (2008) Hepatology , vol.47 , pp. 1158-1166
    • Krasnoff, J.B.1    Painter, P.L.2    Wallace, J.P.3    Bass, N.M.4    Merriman, R.B.5
  • 94
    • 37549047166 scopus 로고    scopus 로고
    • Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions
    • Duseja A, Das A, Dhiman RK, Chawla YK, Thumburu KT, Bhadada S et al. Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol 2007;6:222-67
    • (2007) Ann Hepatol , vol.6 , pp. 222-267
    • Duseja, A.1    Das, A.2    Dhiman, R.K.3    Chawla, Y.K.4    Thumburu, K.T.5    Bhadada, S.6
  • 95
    • 45549091794 scopus 로고    scopus 로고
    • Clinical trial: Insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
    • Idilman R, Mizrak D, Corapcioglu D, Bektas M, Doganay B, Sayki M et al. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2008;28:200-8.
    • (2008) Aliment Pharmacol Ther , vol.28 , pp. 200-208
    • Idilman, R.1    Mizrak, D.2    Corapcioglu, D.3    Bektas, M.4    Doganay, B.5    Sayki, M.6
  • 97
    • 59149094374 scopus 로고    scopus 로고
    • Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents
    • Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr Diabetes 2009;10:5-13.
    • (2009) Pediatr Diabetes , vol.10 , pp. 5-13
    • Nadeau, K.J.1    Ehlers, L.B.2    Zeitler, P.S.3    Love-Osborne, K.4
  • 98
    • 77955470801 scopus 로고    scopus 로고
    • Metformin versus dietary treatment in nonalcoholic hepatic steatosis: A randomized study
    • Lond
    • Garinis GA, Fruci B, Mazza A, De Siena M, Abenavoli S, Gulletta E et al. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes (Lond) 2010;34:1255-64.
    • (2010) Int J Obes , vol.34 , pp. 1255-1264
    • Garinis, G.A.1    Fruci, B.2    Mazza, A.3    De Siena, M.4    Abenavoli, S.5    Gulletta, E.6
  • 102
    • 0034126755 scopus 로고    scopus 로고
    • Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
    • Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-8. (Pubitemid 30415645)
    • (2000) Journal of Pediatrics , vol.136 , Issue.6 , pp. 734-738
    • Lavine, J.E.1
  • 103
    • 33845491494 scopus 로고    scopus 로고
    • Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease
    • DOI 10.1111/j.1365-2036.2006.03161.x
    • Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006;24:1553-61. (Pubitemid 44915203)
    • (2006) Alimentary Pharmacology and Therapeutics , vol.24 , Issue.11-12 , pp. 1553-1561
    • Nobili, V.1    Manco, M.2    Devito, R.3    Ciampalini, P.4    Piemonte, F.5    Marcellini, M.6
  • 104
    • 0034799895 scopus 로고    scopus 로고
    • Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study
    • DOI 10.1046/j.1365-2036.2001.01083.x
    • Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001;15:1667-72. (Pubitemid 32912411)
    • (2001) Alimentary Pharmacology and Therapeutics , vol.15 , Issue.10 , pp. 1667-1672
    • Hasegawa, T.1    Yoneda, M.2    Nakamura, K.3    Makino, I.4    Terano, A.5
  • 106
    • 0042265627 scopus 로고    scopus 로고
    • Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E
    • DOI 10.1053/jhep.2003.50316
    • Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003;38:413-9. (Pubitemid 36919862)
    • (2003) Hepatology , vol.38 , Issue.2 , pp. 413-419
    • Kugelmas, M.1    Hill, D.B.2    Vivian, B.3    Marsano, L.4    McClain, C.J.5
  • 108
    • 0348047323 scopus 로고    scopus 로고
    • Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
    • DOI 10.1016/j.surg.2003.10.003
    • Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004;135:48-58. (Pubitemid 38041453)
    • (2004) Surgery , vol.135 , Issue.1 , pp. 48-58
    • Kral, J.G.1    Thung, S.N.2    Biron, S.3    Hould, F.-S.4    Lebel, S.5    Marceau, S.6    Simard, S.7    Marceau, P.8
  • 109
    • 32044451685 scopus 로고    scopus 로고
    • Roux-En-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease
    • Clark JM, Alkhuraishi AR, Solga SF, Alli P, Diehl AM, Magnuson TH. Roux-En-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res 2005;13:1180-6.
    • (2005) Obes Res , vol.13 , pp. 1180-1186
    • Clark, J.M.1    Alkhuraishi, A.R.2    Solga, S.F.3    Alli, P.4    Diehl, A.M.5    Magnuson, T.H.6
  • 110
    • 26444467171 scopus 로고    scopus 로고
    • Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome
    • discussion 618-20
    • Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 2005;242:610-7; discussion 618-20.
    • (2005) Ann Surg , vol.242 , pp. 610-617
    • Mattar, S.G.1    Velcu, L.M.2    Rabinovitz, M.3    Demetris, A.J.4    Krasinskas, A.M.5    Barinas-Mitchell, E.6
  • 112
    • 33646861774 scopus 로고    scopus 로고
    • Histological findings in the liver before and after gastric bypass
    • DOI 10.1381/096089206776944904
    • Csendes A, Smok G, Burgos AM. Histological findings in the liver before and after gastric bypass. Obes Surg 2006;16:607-11. (Pubitemid 43781046)
    • (2006) Obesity Surgery , vol.16 , Issue.5 , pp. 607-611
    • Csendes, A.1    Smok, G.2    Burgos, A.M.3
  • 114
    • 33750571872 scopus 로고    scopus 로고
    • Weight loss and non-alcoholic fatty liver disease: Falls in gamma-glutamyl transferase concentrations are associated with histologic improvement
    • DOI 10.1381/096089206778663805
    • Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006,16:1278-86. (Pubitemid 44671797)
    • (2006) Obesity Surgery , vol.16 , Issue.10 , pp. 1278-1286
    • Dixon, J.B.1    Bhathal, P.S.2    O'Brien, P.E.3
  • 118
    • 70249115442 scopus 로고    scopus 로고
    • Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression
    • Moschen AR, Molnar C, Wolf AM, Weiss H, Graziadei I, Kaser S et al. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol 2009;51:765-77.
    • (2009) J Hepatol , vol.51 , pp. 765-777
    • Moschen, A.R.1    Molnar, C.2    Wolf, A.M.3    Weiss, H.4    Graziadei, I.5    Kaser, S.6
  • 119
    • 77952579195 scopus 로고    scopus 로고
    • Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
    • Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis 2010;28:274-9.
    • (2010) Dig Dis , vol.28 , pp. 274-279
    • Weiner, R.A.1
  • 120
    • 77953025796 scopus 로고    scopus 로고
    • Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome p-450 protein content
    • Bell LN, Temm CJ, Saxena R, Vuppalanchi R, Schauer P, Rabinovitz M et al. Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome p-450 protein content. Ann Surg 2010;251:1041-8.
    • (2010) Ann Surg , vol.251 , pp. 1041-1048
    • Bell, L.N.1    Temm, C.J.2    Saxena, R.3    Vuppalanchi, R.4    Schauer, P.5    Rabinovitz, M.6
  • 121
    • 34249791215 scopus 로고    scopus 로고
    • Resolution of nonalcoholic steatohepatits after gastric bypass surgery
    • DOI 10.1007/s11695-007-9086-2
    • Liu X, Lazenby AJ, Clements RH, Jhala N, Abrams GA. Resolution of nonalcoholic steatohepatits after gastric bypass surgery. Obes Surg 2007;17:486-92. (Pubitemid 46850188)
    • (2007) Obesity Surgery , vol.17 , Issue.4 , pp. 486-492
    • Liu, X.1    Lazenby, A.J.2    Clements, R.H.3    Jhala, N.4    Abrams, G.A.5
  • 122
    • 21344458564 scopus 로고    scopus 로고
    • Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery
    • DOI 10.1381/0960892054222830
    • Mottin CC, Moretto M, Padoin AV, Kupski C, Swarowsky AM, Glock L et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005;15:788-93. (Pubitemid 40904867)
    • (2005) Obesity Surgery , vol.15 , Issue.6 , pp. 788-793
    • Mottin, C.C.1    Moretto, M.2    Padoin, A.V.3    Kupski, C.4    Swarowsky, A.M.5    Glock, L.6    Duval, V.7    Braga, J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.